BCT.TO vs. BCTX
BCT.TO (BriaCell Therapeutics Corp.) and BCTX (Briacell Therapeutics Corp) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, BCT.TO returned -65.45%/yr vs -65.91%/yr for BCTX. Their correlation of 0.90 suggests significant overlap in exposure.
Performance
BCT.TO vs. BCTX - Performance Comparison
Loading charts...
Different Trading Currencies
BCT.TO is traded in CAD, while BCTX is traded in USD. To make them comparable, the BCTX values have been converted to CAD using the latest available exchange rates.
Returns By Period
The year-to-date returns for both stocks are quite close, with BCT.TO having a -54.18% return and BCTX slightly lower at -56.00%.
BCT.TO
- 1D
- -1.97%
- 1M
- -20.25%
- YTD
- -54.18%
- 6M
- -71.58%
- 1Y
- -90.11%
- 3Y*
- -84.71%
- 5Y*
- -65.45%
- 10Y*
- -16.35%
BCTX
- 1D
- -5.32%
- 1M
- -24.13%
- YTD
- -56.00%
- 6M
- -72.72%
- 1Y
- -90.60%
- 3Y*
- -84.83%
- 5Y*
- -65.91%
- 10Y*
- —
BCT.TO vs. BCTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BCT.TO BriaCell Therapeutics Corp. | -54.18% | -91.93% | -89.62% | 33.48% | -43.54% | 120.00% |
BCTX Briacell Therapeutics Corp | -56.00% | -92.00% | -89.51% | 30.92% | -43.46% | 114.51% |
Correlation
The correlation between BCT.TO and BCTX is 0.93, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.93 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.91 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.90 |
Correlation (All Time) Calculated using the full available price history since Feb 25, 2021 | 0.90 |
The correlation between BCT.TO and BCTX has been stable across timeframes, ranging from 0.90 to 0.93 - a consistent structural relationship.
Fundamentals
BCT.TO:
CA$12.58M
BCTX:
$8.63M
BCT.TO:
-CA$20.91
BCTX:
-$17.52
BCT.TO:
0.30
BCTX:
0.29
BCT.TO:
CA$0.00
BCTX:
$0.00
BCT.TO:
-CA$110.60K
BCTX:
-$111.34K
BCT.TO:
-CA$39.27M
BCTX:
-$31.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BCT.TO vs. BCTX — Risk / Return Rank
BCT.TO
BCTX
BCT.TO vs. BCTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BriaCell Therapeutics Corp. (BCT.TO) and Briacell Therapeutics Corp (BCTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BCT.TO | BCTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.01 | ||
| Sortino ratioReturn per unit of downside risk | +0.08 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 0.81 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | -0.99 | +0.01 |
| Martin ratioReturn relative to average drawdown | -1.18 | -1.19 | +0.01 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BCT.TO | BCTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.67 | -0.69 | +0.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.61 | -0.63 | +0.02 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.00 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.00 | -0.55 | +0.55 |
Drawdowns
BCT.TO vs. BCTX - Drawdown Comparison
The maximum BCT.TO drawdown since its inception was -99.89%, roughly equal to the maximum BCTX drawdown of -99.82%. Use the drawdown chart below to compare losses from any high point for BCT.TO and BCTX.
Loading charts...
Drawdown Indicators
| BCT.TO | BCTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.89% | -99.82% | -0.07% |
Max Drawdown (1Y)Largest decline over 1 year | -91.52% | -91.35% | -0.17% |
Max Drawdown (3Y)Largest decline over 3 years | -99.73% | -99.73% | 0.00% |
Max Drawdown (5Y)Largest decline over 5 years | -99.82% | -99.82% | 0.00% |
Max Drawdown (10Y)Largest decline over 10 years | -99.89% | — | — |
Current DrawdownCurrent decline from peak | -99.88% | -99.81% | -0.07% |
Average DrawdownAverage peak-to-trough decline | -69.21% | -61.04% | -8.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 76.22% | 76.28% | -0.06% |
Volatility
BCT.TO vs. BCTX - Volatility Comparison
BriaCell Therapeutics Corp. (BCT.TO) and Briacell Therapeutics Corp (BCTX) have volatilities of 38.25% and 36.80%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BCT.TO | BCTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 38.25% | 36.80% | +1.45% |
Volatility (6M)Calculated over the trailing 6-month period | 113.14% | 109.29% | +3.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 134.38% | 132.24% | +2.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 108.73% | 105.17% | +3.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13,227.86% | 112.72% | +13,115.14% |
Dividends
BCT.TO vs. BCTX - Dividend Comparison
Neither BCT.TO nor BCTX has paid dividends to shareholders.
Financials
BCT.TO vs. BCTX - Financials Comparison
This section allows you to compare key financial metrics between BriaCell Therapeutics Corp. and Briacell Therapeutics Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
With a correlation of 0.93, BCT.TO and BCTX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
Find the right allocation for BCT.TO and BCTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer